Advertisement

Letrozole stimulation in endometrial preparation for cryopreserved–thawed embryo transfer in women with polycystic ovarian syndrome: A pilot study

Authors

  • Yan-Jun Hu,

    Corresponding author
    1. Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    • Correspondence: Yan-Jun Hu and He-Feng Huang, Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China. Tel.: 86-135-88006497; E-mails: huanghefg@hotmail.com and hyj101@163.com

    Search for more papers by this author
  • Yue-Zhou Chen,

    1. Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Search for more papers by this author
  • Yi-Min Zhu,

    1. Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Search for more papers by this author
  • He-Feng Huang

    Corresponding author
    1. Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    • Correspondence: Yan-Jun Hu and He-Feng Huang, Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China. Tel.: 86-135-88006497; E-mails: huanghefg@hotmail.com and hyj101@163.com

    Search for more papers by this author

Summary

Objective

To study the efficiency of letrozole, an aromatase inhibitor, in endometrial preparation for cryopreserved–thawed embryo transfer (FET) in women with polycystic ovarian syndrome (PCOS).

Design

Retrospective observational study.

Patients

One hundred and twenty patients with PCOS who met the inclusion criteria for the study.

Measurements

We assessed in vitro fertilization outcomes in one hundred and twenty patients with PCOS (148 cycles) who were prepared for and underwent FET between June 2011 and December 2012. Patients were prepared for FET using artificial hormone cycles induced with oestrogen and progesterone supplementation (n = 76), letrozole stimulation (n = 40) or hMG stimulation (n = 32).

Results

There were no differences in demographic characteristics between the groups, except that the letrozole group had a higher incidence of embryo transfer failure in the past. The letrozole stimulation group had a significantly higher maximal endometrial thickness and significantly higher rates of clinical pregnancy per transfer, ongoing pregnancy per transfer and implantation, compared with the artificial and hMG stimulation groups. Differences in these parameters between the artificial and hMG stimulation groups were not significant.

Conclusion

Using letrozole stimulation in endometrial preparation for cryopreserved–thawed embryo transfer in patients with PCOS may be associated with better outcomes than using hormonal manipulation or hMG stimulation.

Ancillary